Clinical Trial Update: Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of Phase 1 and Phase 2 trials evaluating ruxolitinib for chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED